47. Johansson N, Airola K, Grenman R, Kariniemi AL, Saarialho-Kere U, et al. (1997) Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. Am J Pathol 151: 499–508. 48. Wu N, Opalenik S, Liu J, Jansen ED, Giro MG, et al. (2002) Real-time visualization of MMP-13 promoter activity in transgenic mice. Matrix Biol 21: 149–161. 49. Luukkaa M, Vihinen P, Kronqvist P, Vahlberg T, Pyrhonen S, et al. (2006) Association between high collagenase-3 expression levels and poor prognosis in patients with head and neck cancer. Head Neck 28: 225–234. 50. Dunne AA, Sesterhenn A, Gerisch A, Teymoortash A, Kuropkat C, et al. (2003) Expression of MMP-2, -9 and -13 in cell lines and fresh biopsies of squamous cell carcinomas of the upper aerodigestive tract. Anticancer Res 23: 2233–2239. 51. Dittmer J (2003) The biology of the Ets1 proto-oncogene. Mol Cancer 2: 29. 52. List K, Szabo R, Molinolo A, Sriuranpong V, Redeye V, et al. (2005) Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation. Genes Dev 19: 1934–1950. 53. Kuramoto N, Takizawa T, Matsuki M, Morioka H, Robinson JM, et al. (2002) Development of ichthyosiform skin compensates for defective permeability barrier function in mice lacking transglutaminase 1. J Clin Invest 109: 243–250. 54. Owens DM, Watt FM (2003) Contribution of stem cells and differentiated cells to epidermal tumours. Nat Rev Cancer 3: 444–451. 55. Perez-Losada J, Balmain A (2003) Stem-cell hierarchy in skin cancer. Nat Rev Cancer 3: 434–443. 56. Vitale-Cross L, Amornphimoltham P, Fisher G, Molinolo AA, Gutkind JS (2004) Conditional expression of K-ras in an epithelial compartment that includes the stem cells is sufficient to promote squamous cell carcinogenesis. Cancer Res 64: 8804–8807. 57. Pelengaris S, Littlewood T, Khan M, Elia G, Evan G (1999) Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion. Mol Cell 3: 565–577. 58. Arnold I, Watt FM (2001) c-Myc activation in transgenic mouse epidermis results in mobilization of stem cells and differentiation of their progeny. Curr Biol 11: 558–568. 59. Bull JJ, Pelengaris S, Hendrix S, Chronnell CM, Khan M, et al. (2005) Ectopic expression of c-Myc in the skin affects the hair growth cycle and causes an enlargement of the sebaceous gland. Br J Dermatol 152: 1125–1133. 60. Saez E, Rutberg SE, Mueller E, Oppenheim H, Smoluk J, et al. (1995) c-fos is required for malignant progression of skin tumors. Cell 82: 721–732. 61. Johnson R, Spiegelman B, Hanahan D, Wisdom R (1996) Cellular transforma- tion and malignancy induced by ras require c-jun. Mol Cell Biol 16: 4504–4511. 62. Leeman MF, Curran S, Murray GI (2002) The structure, regulation, and function of human matrix metalloproteinase-13. Crit Rev Biochem Mol Biol 37: 149–166. Ets1 in Squamous Neoplasia 63. Lochter A, Galosy S, Muschler J, Freedman N, Werb Z, et al. (1997) Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J Cell Biol 139: 1861–1872. 64. Symowicz J, Adley BP, Gleason KJ, Johnson JJ, Ghosh S, et al. (2007) Engagement of collagen-binding integrins promotes matrix metalloproteinase-9- dependent E-cadherin ectodomain shedding in ovarian carcinoma cells. Cancer Res 67: 2030–2039. 65. Lee KH, Choi EY, Hyun MS, Jang BI, Kim TN, et al. (2007) Association of extracellular cleavage of E-cadherin mediated by MMP-7 with HGF-induced in vitro invasion in human stomach cancer cells. Eur Surg Res 39: 208–215. 66. Cirillo N, Femiano F, Gombos F, Lanza A (2007) Metalloproteinase 9 is the outer executioner of desmoglein 3 in apoptotic keratinocytes. Oral Dis 13: 341–345. 67. Davies G, Jiang WG, Mason MD (2001) Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion. Clin Cancer Res 7: 3289–3297. 68. Weiske J, Schoneberg T, Schroder W, Hatzfeld M, Tauber R, et al. (2001) The fate of desmosomal proteins in apoptotic cells. J Biol Chem 276: 41175–41181. 69. D’Armiento J, DiColandrea T, Dalal SS, Okada Y, Huang MT, et al. (1995) Collagenase expression in transgenic mouse skin causes hyperkeratosis and acanthosis and increases susceptibility to tumorigenesis. Mol Cell Biol 15: 5732–5739. 70. Rudolph-Owen LA, Chan R, Muller WJ, Matrisian LM (1998) The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis. Cancer Res 58: 5500–5506. 71. Sternlicht MD, Bissell MJ, Werb Z (2000) The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter. Oncogene 19: 1102–1113. 72. Ha HY, Moon HB, Nam MS, Lee JW, Ryoo ZY, et al. (2001) Overexpression of membrane-type matrix metalloproteinase-1 gene induces mammary gland abnormalities and adenocarcinoma in transgenic mice. Cancer Res 61: 984–990. 73. Jin X, Yagi M, Akiyama N, Hirosaki T, Higashi S, et al. (2006) Matriptase activates stromelysin (MMP-3) and promotes tumor growth and angiogenesis. Cancer Sci 97: 1327–1334. 74. John SA, Clements JL, Russell LM, Garrett-Sinha LA (2007) Ets-1 regulates plasma cell differentiation by interfering with the activity of the transcription factor blimp-1. J Biol Chem. 75. Magnusdottir E, Kalachikov S, Mizukoshi K, Savitsky D, Ishida-Yamamoto A, et al. (2007) Epidermal terminal differentiation depends on B lymphocyte- induced maturation protein-1. Proc Natl Acad Sci U S A 104: 14988–14993. PLoS ONE | www.plosone.org 15 January 2009 | Volume 4 | Issue 1 | e4179